<DOC>
	<DOCNO>NCT01254240</DOCNO>
	<brief_summary>This double-blind prospective randomize monocenter study compare efficacy two phototherapy ultraviolet spectrum pruritus ( itch ) inflammatory skin disease . 40 patient per treatment , total 80 study participant .</brief_summary>
	<brief_title>Efficacy Study Two Choices Phototherapy Itching Skin Diseases</brief_title>
	<detailed_description>In patient skin disease give indication phototherapy Ultraviolet B narrow-band ( UVB narrowband , 311nm ) without Ultraviolet A ( UVA , 320-400 nm ) , subjective pruritus level clinical severity measure , completion 16-week therapy ( 40 patient per group ) . Patients recruit department dermatology University Hospital ZÃ¼rich outpatient clinic . Following oral write consent , pruritus level measure visual analogue scale new , detailed pruritus score 2 start therapy , every 4 week start well completion phototherapy . Phototherapy administer 3 time per week . The study include 5 study visit 43 treatment visit include administration phototherapy . A physical examination include clinical score ( Psoriasis Area Severity Index PASI , Eczema Area Severity Index EASI , Physician 's static global assessment PSGA Dermatology Dynamics Vector DDV ) perform every visit . During first physical examination Fitzpatrick-skin type patient record , demographic , Body Mass Index ( BMI ) , diagnosis , past medical history , co-morbidities , concomitant medication number past UVA/B treatment .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Inclusion criterion : Pruritic inflammatory disease atopic dermatitis , type eczema , psoriasis , prurigo simplex subacuta others . Main inclusion criterion : Pruritus VAS Score 5 high screening . Dermatological indication phototherapy UVB nb / UVA Oral write informed patient consent Exclusion criterion : Patients exclude study fulfill follow criterion : 1 . Foreseeable interruption light therapy 14 day , interruption light therapy 14 day study 2 . Heightened photosensitivity UVA UVB 3 . Withdrawal consent participate 4 . Concomitant participation another study take part another clinical study within last 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>